BIOAVAILABILITY OF PHENYLPROPANOLAMINE HCL FROM TABLET DOSAGE FORMS CONTAINING CROSCARMELLOSE SODIUM

被引：19
作者：
HOLLENBECK, RG
机构：
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1988年 / 47卷 / 1-3期
关键词：
D O I：
10.1016/0378-5173(88)90218-9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：89 / 93
页数：5
相关论文
共 8 条
[1]  
[Anonymous], 1976, MERCK INDEX, V9th
[2]   DRUG-DISINTEGRANT INTERACTIONS - BINDING OF OXYMORPHONE DERIVATIVES [J].
CHIEN, YW ;
VANNOSTRAND, P ;
HURWITZ, AR ;
SHAMI, EG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (06) :709-710
[3]   DETERMINATION OF PHENYLPROPANOLAMINE IN SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DOWSE, R ;
HAIGH, JM ;
KANFER, I .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (09) :1018-1020
[4]  
FAN AC, 1985, THESIS U MARYLAND
[5]   USP STANDARDS FOR DISSOLUTION AND BIOAVAILABILITY [J].
GRADY, LT .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1982, 39 (09) :1546-1548
[6]   ESTIMATION OF THE EXTENT OF DRUG EXCIPIENT INTERACTIONS INVOLVING CROSCARMELLOSE SODIUM [J].
HOLLENBECK, RG ;
MITREVEJ, KT ;
FAN, AC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (03) :325-327
[7]  
SINSHEIMER J E, 1973, Biochemical Society Transactions, V1, P1160
[8]  
1985, US PHARMACOPEIA
1